4D Molecular Therapeutics Inc
(FDMT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 92 | 1,366 | 14,580 | 2,000 | -977 |
| Gross Profit | 92 | 1,366 | 14,580 | 2,000 | 4,444 |
| Operating Expenses | 24,856 | 24,027 | 22,176 | 18,312 | 19,445 |
| Operating Income | -24,764 | -22,661 | -7,596 | -16,312 | -20,422 |
| Other Income | -319 | 422 | 7 | -94 | -125 |
| Pre-tax Income | -25,083 | -22,239 | -7,589 | -16,406 | -20,547 |
| Net Income Continuous | -25,083 | -22,239 | -7,589 | -16,406 | -20,547 |
| Net Income | $-25,083 | $-22,239 | $-7,589 | $-16,406 | $-20,547 |
| EPS Basic Total Ops | -0.86 | -0.82 | -0.28 | -0.61 | -1.85 |
| EPS Basic Continuous Ops | -0.85 | -0.82 | -0.28 | -0.61 | -1.85 |
| EPS Diluted Total Ops | -0.86 | -0.82 | -0.28 | -0.61 | -1.85 |
| EPS Diluted Continuous Ops | -0.85 | -0.82 | -0.28 | -0.61 | -1.85 |
| EBITDA(a) | $-23,655 | $-22,281 | $-7,226 | $-15,929 | $-20,051 |